Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage

We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The first case involved an 84-year-old woman who devel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain tumor pathology 2014-07, Vol.31 (3), p.222-228
Hauptverfasser: Matsuyama, Junko, Ichikawa, Masahiro, Oikawa, Tomoyoshi, Sato, Taku, Kishida, Yugo, Oda, Keiko, Maeda, Takuya, Yamada, Masayuki, Kuromi, Yosuke, Matsumoto, Yuka, Ando, Hitoshi, Sakuma, Jun, Saito, Kiyoshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 228
container_issue 3
container_start_page 222
container_title Brain tumor pathology
container_volume 31
creator Matsuyama, Junko
Ichikawa, Masahiro
Oikawa, Tomoyoshi
Sato, Taku
Kishida, Yugo
Oda, Keiko
Maeda, Takuya
Yamada, Masayuki
Kuromi, Yosuke
Matsumoto, Yuka
Ando, Hitoshi
Sakuma, Jun
Saito, Kiyoshi
description We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The first case involved an 84-year-old woman who developed loss of vision and hypopituitarism. Intraoperative finding was optic glioma; histological diagnosis was diffuse large B cell lymphoma, however. The second case involved a 67-year-old man who developed loss of vision. The pre-surgical diagnosis was optic nerve neuritis; this was then revised to granuloma. The tumor arose in the optic nerve. Methotrexate and rituximab were administered and the patient remained in complete remission for 3 years. However, a sudden intratumoral hemorrhage occurred. Although most of the lymphoma cells obtained from the initial surgery were negative for vascular endothelial growth factor (VEGF) immunoreactivity, high levels of VEGF immunoreactivity in lymphoma cells was detected in the specimen obtained after intratumoral bleeding at recurrence, and correlation between VEGF reactivity and tumor recurrence was suggested. To date, primary CNS lymphomas with intracerebral hemorrhage have been reported in 3 cases only, and a correlation between intratumoral hemorrhage and the degree of VEGF expression has been suggested. VEGF also might have predictive significance for recurrence.
doi_str_mv 10.1007/s10014-013-0159-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1548638727</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1548638727</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-9e8f63b2289de6649cd06b56e8064fee1bf23bb9543322f98716c6e801df4de53</originalsourceid><addsrcrecordid>eNp1kduK1jAUhYMozjj6AN5IwBsvrObQ5uDd8OMJBhVU8C6k6e7fDG1Sk3ZknsjXNJ2OCoIXOWz2t1bCXgg9puQFJUS-zGWndUUoL6vRlbqDTqkStOJKfrtb7jXnleRanaAHOV8SUtdE0vvohHGttRTyFP38lPxk0zU-fPiMx-tpHuJksU0--3DEPuBlAJzg6GPAsb-p4rx4hwOkK8Bzggxh2Vib8Rhz3qiroo7hFWbY2bzJ55iW_LzYuXHtbmA828UXJf7hl6GUk83ZF0MflmQdJGiTHfEAU0xpsEd4iO71dszw6PY8Q1_fvP5yeFddfHz7_nB-UblaiKXSoHrBW8aU7kCIWruOiLYRoIioewDa9oy3rW7KZBjrtZJUuK1Lu77uoOFn6NnuO6f4fYW8mMlnB-NoA8Q1G9rUSpTxMlnQp_-gl3FNofzOME0VaSRTmyHdKZfKdBL0Zt4nbigxW4pmT9GUFM2WolFF8-TWeW0n6P4ofsdWALYDubTCEdLfp__v-gtHQKmc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918057285</pqid></control><display><type>article</type><title>Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage</title><source>MEDLINE</source><source>ProQuest Central (Alumni Edition)</source><source>ProQuest Central UK/Ireland</source><source>SpringerLink Journals - AutoHoldings</source><source>ProQuest Central</source><creator>Matsuyama, Junko ; Ichikawa, Masahiro ; Oikawa, Tomoyoshi ; Sato, Taku ; Kishida, Yugo ; Oda, Keiko ; Maeda, Takuya ; Yamada, Masayuki ; Kuromi, Yosuke ; Matsumoto, Yuka ; Ando, Hitoshi ; Sakuma, Jun ; Saito, Kiyoshi</creator><creatorcontrib>Matsuyama, Junko ; Ichikawa, Masahiro ; Oikawa, Tomoyoshi ; Sato, Taku ; Kishida, Yugo ; Oda, Keiko ; Maeda, Takuya ; Yamada, Masayuki ; Kuromi, Yosuke ; Matsumoto, Yuka ; Ando, Hitoshi ; Sakuma, Jun ; Saito, Kiyoshi</creatorcontrib><description>We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The first case involved an 84-year-old woman who developed loss of vision and hypopituitarism. Intraoperative finding was optic glioma; histological diagnosis was diffuse large B cell lymphoma, however. The second case involved a 67-year-old man who developed loss of vision. The pre-surgical diagnosis was optic nerve neuritis; this was then revised to granuloma. The tumor arose in the optic nerve. Methotrexate and rituximab were administered and the patient remained in complete remission for 3 years. However, a sudden intratumoral hemorrhage occurred. Although most of the lymphoma cells obtained from the initial surgery were negative for vascular endothelial growth factor (VEGF) immunoreactivity, high levels of VEGF immunoreactivity in lymphoma cells was detected in the specimen obtained after intratumoral bleeding at recurrence, and correlation between VEGF reactivity and tumor recurrence was suggested. To date, primary CNS lymphomas with intracerebral hemorrhage have been reported in 3 cases only, and a correlation between intratumoral hemorrhage and the degree of VEGF expression has been suggested. VEGF also might have predictive significance for recurrence.</description><identifier>ISSN: 1433-7398</identifier><identifier>EISSN: 1861-387X</identifier><identifier>DOI: 10.1007/s10014-013-0159-8</identifier><identifier>PMID: 23999767</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Murine-Derived - administration &amp; dosage ; Antineoplastic Combined Chemotherapy Protocols ; Biomarkers - metabolism ; Biopsy ; Blindness - etiology ; Cancer Research ; Case Report ; Case reports ; Cerebral Hemorrhage - diagnosis ; Cerebral Hemorrhage - etiology ; Chemotherapy ; Epstein-Barr virus ; Female ; Hematoma ; Hemorrhage ; Humans ; Hypopituitarism - etiology ; Lymphocytes ; Lymphoma ; Lymphoma, Large B-Cell, Diffuse - complications ; Lymphoma, Large B-Cell, Diffuse - drug therapy ; Lymphoma, Large B-Cell, Diffuse - pathology ; Lymphoma, Large B-Cell, Diffuse - surgery ; Magnetic resonance imaging ; Male ; Medical imaging ; Medicine ; Medicine &amp; Public Health ; Methotrexate - administration &amp; dosage ; Neoplasm Recurrence, Local ; Nervous system ; Neurology ; Neurosurgery ; Oncology ; Ophthalmology ; Optic nerve ; Optic Nerve Neoplasms - complications ; Optic Nerve Neoplasms - drug therapy ; Optic Nerve Neoplasms - pathology ; Optic Nerve Neoplasms - surgery ; Pathology ; Predictive Value of Tests ; Radiation therapy ; Remission Induction ; Rituximab ; Steroids ; Stroke ; Tomography ; Tumors ; Vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - metabolism ; Visual acuity</subject><ispartof>Brain tumor pathology, 2014-07, Vol.31 (3), p.222-228</ispartof><rights>The Japan Society of Brain Tumor Pathology 2013</rights><rights>The Japan Society of Brain Tumor Pathology 2013.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-9e8f63b2289de6649cd06b56e8064fee1bf23bb9543322f98716c6e801df4de53</citedby><cites>FETCH-LOGICAL-c466t-9e8f63b2289de6649cd06b56e8064fee1bf23bb9543322f98716c6e801df4de53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10014-013-0159-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2918057285?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,21388,21389,27924,27925,33530,33531,33744,33745,41488,42557,43659,43805,51319,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23999767$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsuyama, Junko</creatorcontrib><creatorcontrib>Ichikawa, Masahiro</creatorcontrib><creatorcontrib>Oikawa, Tomoyoshi</creatorcontrib><creatorcontrib>Sato, Taku</creatorcontrib><creatorcontrib>Kishida, Yugo</creatorcontrib><creatorcontrib>Oda, Keiko</creatorcontrib><creatorcontrib>Maeda, Takuya</creatorcontrib><creatorcontrib>Yamada, Masayuki</creatorcontrib><creatorcontrib>Kuromi, Yosuke</creatorcontrib><creatorcontrib>Matsumoto, Yuka</creatorcontrib><creatorcontrib>Ando, Hitoshi</creatorcontrib><creatorcontrib>Sakuma, Jun</creatorcontrib><creatorcontrib>Saito, Kiyoshi</creatorcontrib><title>Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage</title><title>Brain tumor pathology</title><addtitle>Brain Tumor Pathol</addtitle><addtitle>Brain Tumor Pathol</addtitle><description>We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The first case involved an 84-year-old woman who developed loss of vision and hypopituitarism. Intraoperative finding was optic glioma; histological diagnosis was diffuse large B cell lymphoma, however. The second case involved a 67-year-old man who developed loss of vision. The pre-surgical diagnosis was optic nerve neuritis; this was then revised to granuloma. The tumor arose in the optic nerve. Methotrexate and rituximab were administered and the patient remained in complete remission for 3 years. However, a sudden intratumoral hemorrhage occurred. Although most of the lymphoma cells obtained from the initial surgery were negative for vascular endothelial growth factor (VEGF) immunoreactivity, high levels of VEGF immunoreactivity in lymphoma cells was detected in the specimen obtained after intratumoral bleeding at recurrence, and correlation between VEGF reactivity and tumor recurrence was suggested. To date, primary CNS lymphomas with intracerebral hemorrhage have been reported in 3 cases only, and a correlation between intratumoral hemorrhage and the degree of VEGF expression has been suggested. VEGF also might have predictive significance for recurrence.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies, Monoclonal, Murine-Derived - administration &amp; dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols</subject><subject>Biomarkers - metabolism</subject><subject>Biopsy</subject><subject>Blindness - etiology</subject><subject>Cancer Research</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Cerebral Hemorrhage - diagnosis</subject><subject>Cerebral Hemorrhage - etiology</subject><subject>Chemotherapy</subject><subject>Epstein-Barr virus</subject><subject>Female</subject><subject>Hematoma</subject><subject>Hemorrhage</subject><subject>Humans</subject><subject>Hypopituitarism - etiology</subject><subject>Lymphocytes</subject><subject>Lymphoma</subject><subject>Lymphoma, Large B-Cell, Diffuse - complications</subject><subject>Lymphoma, Large B-Cell, Diffuse - drug therapy</subject><subject>Lymphoma, Large B-Cell, Diffuse - pathology</subject><subject>Lymphoma, Large B-Cell, Diffuse - surgery</subject><subject>Magnetic resonance imaging</subject><subject>Male</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Methotrexate - administration &amp; dosage</subject><subject>Neoplasm Recurrence, Local</subject><subject>Nervous system</subject><subject>Neurology</subject><subject>Neurosurgery</subject><subject>Oncology</subject><subject>Ophthalmology</subject><subject>Optic nerve</subject><subject>Optic Nerve Neoplasms - complications</subject><subject>Optic Nerve Neoplasms - drug therapy</subject><subject>Optic Nerve Neoplasms - pathology</subject><subject>Optic Nerve Neoplasms - surgery</subject><subject>Pathology</subject><subject>Predictive Value of Tests</subject><subject>Radiation therapy</subject><subject>Remission Induction</subject><subject>Rituximab</subject><subject>Steroids</subject><subject>Stroke</subject><subject>Tomography</subject><subject>Tumors</subject><subject>Vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><subject>Visual acuity</subject><issn>1433-7398</issn><issn>1861-387X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kduK1jAUhYMozjj6AN5IwBsvrObQ5uDd8OMJBhVU8C6k6e7fDG1Sk3ZknsjXNJ2OCoIXOWz2t1bCXgg9puQFJUS-zGWndUUoL6vRlbqDTqkStOJKfrtb7jXnleRanaAHOV8SUtdE0vvohHGttRTyFP38lPxk0zU-fPiMx-tpHuJksU0--3DEPuBlAJzg6GPAsb-p4rx4hwOkK8Bzggxh2Vib8Rhz3qiroo7hFWbY2bzJ55iW_LzYuXHtbmA828UXJf7hl6GUk83ZF0MflmQdJGiTHfEAU0xpsEd4iO71dszw6PY8Q1_fvP5yeFddfHz7_nB-UblaiKXSoHrBW8aU7kCIWruOiLYRoIioewDa9oy3rW7KZBjrtZJUuK1Lu77uoOFn6NnuO6f4fYW8mMlnB-NoA8Q1G9rUSpTxMlnQp_-gl3FNofzOME0VaSRTmyHdKZfKdBL0Zt4nbigxW4pmT9GUFM2WolFF8-TWeW0n6P4ofsdWALYDubTCEdLfp__v-gtHQKmc</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Matsuyama, Junko</creator><creator>Ichikawa, Masahiro</creator><creator>Oikawa, Tomoyoshi</creator><creator>Sato, Taku</creator><creator>Kishida, Yugo</creator><creator>Oda, Keiko</creator><creator>Maeda, Takuya</creator><creator>Yamada, Masayuki</creator><creator>Kuromi, Yosuke</creator><creator>Matsumoto, Yuka</creator><creator>Ando, Hitoshi</creator><creator>Sakuma, Jun</creator><creator>Saito, Kiyoshi</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>7X8</scope></search><sort><creationdate>20140701</creationdate><title>Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage</title><author>Matsuyama, Junko ; Ichikawa, Masahiro ; Oikawa, Tomoyoshi ; Sato, Taku ; Kishida, Yugo ; Oda, Keiko ; Maeda, Takuya ; Yamada, Masayuki ; Kuromi, Yosuke ; Matsumoto, Yuka ; Ando, Hitoshi ; Sakuma, Jun ; Saito, Kiyoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-9e8f63b2289de6649cd06b56e8064fee1bf23bb9543322f98716c6e801df4de53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies, Monoclonal, Murine-Derived - administration &amp; dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols</topic><topic>Biomarkers - metabolism</topic><topic>Biopsy</topic><topic>Blindness - etiology</topic><topic>Cancer Research</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Cerebral Hemorrhage - diagnosis</topic><topic>Cerebral Hemorrhage - etiology</topic><topic>Chemotherapy</topic><topic>Epstein-Barr virus</topic><topic>Female</topic><topic>Hematoma</topic><topic>Hemorrhage</topic><topic>Humans</topic><topic>Hypopituitarism - etiology</topic><topic>Lymphocytes</topic><topic>Lymphoma</topic><topic>Lymphoma, Large B-Cell, Diffuse - complications</topic><topic>Lymphoma, Large B-Cell, Diffuse - drug therapy</topic><topic>Lymphoma, Large B-Cell, Diffuse - pathology</topic><topic>Lymphoma, Large B-Cell, Diffuse - surgery</topic><topic>Magnetic resonance imaging</topic><topic>Male</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Methotrexate - administration &amp; dosage</topic><topic>Neoplasm Recurrence, Local</topic><topic>Nervous system</topic><topic>Neurology</topic><topic>Neurosurgery</topic><topic>Oncology</topic><topic>Ophthalmology</topic><topic>Optic nerve</topic><topic>Optic Nerve Neoplasms - complications</topic><topic>Optic Nerve Neoplasms - drug therapy</topic><topic>Optic Nerve Neoplasms - pathology</topic><topic>Optic Nerve Neoplasms - surgery</topic><topic>Pathology</topic><topic>Predictive Value of Tests</topic><topic>Radiation therapy</topic><topic>Remission Induction</topic><topic>Rituximab</topic><topic>Steroids</topic><topic>Stroke</topic><topic>Tomography</topic><topic>Tumors</topic><topic>Vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><topic>Visual acuity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsuyama, Junko</creatorcontrib><creatorcontrib>Ichikawa, Masahiro</creatorcontrib><creatorcontrib>Oikawa, Tomoyoshi</creatorcontrib><creatorcontrib>Sato, Taku</creatorcontrib><creatorcontrib>Kishida, Yugo</creatorcontrib><creatorcontrib>Oda, Keiko</creatorcontrib><creatorcontrib>Maeda, Takuya</creatorcontrib><creatorcontrib>Yamada, Masayuki</creatorcontrib><creatorcontrib>Kuromi, Yosuke</creatorcontrib><creatorcontrib>Matsumoto, Yuka</creatorcontrib><creatorcontrib>Ando, Hitoshi</creatorcontrib><creatorcontrib>Sakuma, Jun</creatorcontrib><creatorcontrib>Saito, Kiyoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><jtitle>Brain tumor pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsuyama, Junko</au><au>Ichikawa, Masahiro</au><au>Oikawa, Tomoyoshi</au><au>Sato, Taku</au><au>Kishida, Yugo</au><au>Oda, Keiko</au><au>Maeda, Takuya</au><au>Yamada, Masayuki</au><au>Kuromi, Yosuke</au><au>Matsumoto, Yuka</au><au>Ando, Hitoshi</au><au>Sakuma, Jun</au><au>Saito, Kiyoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage</atitle><jtitle>Brain tumor pathology</jtitle><stitle>Brain Tumor Pathol</stitle><addtitle>Brain Tumor Pathol</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>31</volume><issue>3</issue><spage>222</spage><epage>228</epage><pages>222-228</pages><issn>1433-7398</issn><eissn>1861-387X</eissn><abstract>We report 2 cases of primary central nervous system (CNS) lymphoma arising in the region of the optic nerve. For both patients, diagnosis of lymphoma was impossible without histological examination because of the rarity of the lymphoma location. The first case involved an 84-year-old woman who developed loss of vision and hypopituitarism. Intraoperative finding was optic glioma; histological diagnosis was diffuse large B cell lymphoma, however. The second case involved a 67-year-old man who developed loss of vision. The pre-surgical diagnosis was optic nerve neuritis; this was then revised to granuloma. The tumor arose in the optic nerve. Methotrexate and rituximab were administered and the patient remained in complete remission for 3 years. However, a sudden intratumoral hemorrhage occurred. Although most of the lymphoma cells obtained from the initial surgery were negative for vascular endothelial growth factor (VEGF) immunoreactivity, high levels of VEGF immunoreactivity in lymphoma cells was detected in the specimen obtained after intratumoral bleeding at recurrence, and correlation between VEGF reactivity and tumor recurrence was suggested. To date, primary CNS lymphomas with intracerebral hemorrhage have been reported in 3 cases only, and a correlation between intratumoral hemorrhage and the degree of VEGF expression has been suggested. VEGF also might have predictive significance for recurrence.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>23999767</pmid><doi>10.1007/s10014-013-0159-8</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1433-7398
ispartof Brain tumor pathology, 2014-07, Vol.31 (3), p.222-228
issn 1433-7398
1861-387X
language eng
recordid cdi_proquest_miscellaneous_1548638727
source MEDLINE; ProQuest Central (Alumni Edition); ProQuest Central UK/Ireland; SpringerLink Journals - AutoHoldings; ProQuest Central
subjects Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived - administration & dosage
Antineoplastic Combined Chemotherapy Protocols
Biomarkers - metabolism
Biopsy
Blindness - etiology
Cancer Research
Case Report
Case reports
Cerebral Hemorrhage - diagnosis
Cerebral Hemorrhage - etiology
Chemotherapy
Epstein-Barr virus
Female
Hematoma
Hemorrhage
Humans
Hypopituitarism - etiology
Lymphocytes
Lymphoma
Lymphoma, Large B-Cell, Diffuse - complications
Lymphoma, Large B-Cell, Diffuse - drug therapy
Lymphoma, Large B-Cell, Diffuse - pathology
Lymphoma, Large B-Cell, Diffuse - surgery
Magnetic resonance imaging
Male
Medical imaging
Medicine
Medicine & Public Health
Methotrexate - administration & dosage
Neoplasm Recurrence, Local
Nervous system
Neurology
Neurosurgery
Oncology
Ophthalmology
Optic nerve
Optic Nerve Neoplasms - complications
Optic Nerve Neoplasms - drug therapy
Optic Nerve Neoplasms - pathology
Optic Nerve Neoplasms - surgery
Pathology
Predictive Value of Tests
Radiation therapy
Remission Induction
Rituximab
Steroids
Stroke
Tomography
Tumors
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - metabolism
Visual acuity
title Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20CNS%20lymphoma%20arising%20in%20the%20region%20of%20the%20optic%20nerve%20presenting%20as%20loss%20of%20vision:%202%20case%20reports,%20including%20a%20patient%20with%20a%20massive%20intracerebral%20hemorrhage&rft.jtitle=Brain%20tumor%20pathology&rft.au=Matsuyama,%20Junko&rft.date=2014-07-01&rft.volume=31&rft.issue=3&rft.spage=222&rft.epage=228&rft.pages=222-228&rft.issn=1433-7398&rft.eissn=1861-387X&rft_id=info:doi/10.1007/s10014-013-0159-8&rft_dat=%3Cproquest_cross%3E1548638727%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2918057285&rft_id=info:pmid/23999767&rfr_iscdi=true